Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C17H14O3 |
| Molecular Weight | 266.2913 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCC1=C(C(=O)C2=CC=C(O)C=C2)C3=C(O1)C=CC=C3
InChI
InChIKey=RFRXIWQYSOIBDI-UHFFFAOYSA-N
InChI=1S/C17H14O3/c1-2-14-16(13-5-3-4-6-15(13)20-14)17(19)11-7-9-12(18)10-8-11/h3-10,18H,2H2,1H3
| Molecular Formula | C17H14O3 |
| Molecular Weight | 266.2913 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Interactions of urate transporter URAT1 in human kidney with uricosuric drugs. | 2011-02 |
|
| Current concepts of mechanisms in drug-induced hepatotoxicity. | 2009 |
|
| Mechanisms of benzarone and benzbromarone-induced hepatic toxicity. | 2005-04 |
|
| Severe hepatotoxicity related to benzarone: a report of three cases with two fatalities. | 1995-02 |
|
| Subfulminant hepatitis requiring liver transplantation after benzarone administration. | 1994-06 |
|
| [Drug-induced hepatitis due to benzarone (Fragivix): apropos of a clinical case report]. | 1990-09-01 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:45:59 GMT 2025
by
admin
on
Mon Mar 31 17:45:59 GMT 2025
|
| Record UNII |
23ZW4BG89C
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29750
Created by
admin on Mon Mar 31 17:45:59 GMT 2025 , Edited by admin on Mon Mar 31 17:45:59 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
23ZW4BG89C
Created by
admin on Mon Mar 31 17:45:59 GMT 2025 , Edited by admin on Mon Mar 31 17:45:59 GMT 2025
|
PRIMARY | |||
|
m580
Created by
admin on Mon Mar 31 17:45:59 GMT 2025 , Edited by admin on Mon Mar 31 17:45:59 GMT 2025
|
PRIMARY | Merck Index | ||
|
216-026-2
Created by
admin on Mon Mar 31 17:45:59 GMT 2025 , Edited by admin on Mon Mar 31 17:45:59 GMT 2025
|
PRIMARY | |||
|
CHEMBL1474963
Created by
admin on Mon Mar 31 17:45:59 GMT 2025 , Edited by admin on Mon Mar 31 17:45:59 GMT 2025
|
PRIMARY | |||
|
255968
Created by
admin on Mon Mar 31 17:45:59 GMT 2025 , Edited by admin on Mon Mar 31 17:45:59 GMT 2025
|
PRIMARY | |||
|
1426
Created by
admin on Mon Mar 31 17:45:59 GMT 2025 , Edited by admin on Mon Mar 31 17:45:59 GMT 2025
|
PRIMARY | |||
|
18923
Created by
admin on Mon Mar 31 17:45:59 GMT 2025 , Edited by admin on Mon Mar 31 17:45:59 GMT 2025
|
PRIMARY | RxNorm | ||
|
SUB05740MIG
Created by
admin on Mon Mar 31 17:45:59 GMT 2025 , Edited by admin on Mon Mar 31 17:45:59 GMT 2025
|
PRIMARY | |||
|
C74411
Created by
admin on Mon Mar 31 17:45:59 GMT 2025 , Edited by admin on Mon Mar 31 17:45:59 GMT 2025
|
PRIMARY | |||
|
C004528
Created by
admin on Mon Mar 31 17:45:59 GMT 2025 , Edited by admin on Mon Mar 31 17:45:59 GMT 2025
|
PRIMARY | |||
|
317
Created by
admin on Mon Mar 31 17:45:59 GMT 2025 , Edited by admin on Mon Mar 31 17:45:59 GMT 2025
|
PRIMARY | |||
|
DTXSID2061721
Created by
admin on Mon Mar 31 17:45:59 GMT 2025 , Edited by admin on Mon Mar 31 17:45:59 GMT 2025
|
PRIMARY | |||
|
82134
Created by
admin on Mon Mar 31 17:45:59 GMT 2025 , Edited by admin on Mon Mar 31 17:45:59 GMT 2025
|
PRIMARY | |||
|
1477-19-6
Created by
admin on Mon Mar 31 17:45:59 GMT 2025 , Edited by admin on Mon Mar 31 17:45:59 GMT 2025
|
PRIMARY | |||
|
100000086361
Created by
admin on Mon Mar 31 17:45:59 GMT 2025 , Edited by admin on Mon Mar 31 17:45:59 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
